GTG Global Collaborations and Innovation Update
MELBOURNE, Australia, March 26, 2024 — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to highlight a summary of the Company’s commitment to innovation. This innovation is driven by: Strong global academic relationships with research groups Continuous development of the […]
GTG Global Collaborations and Innovation Update Read More »